Presentation description
Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. Five-year survival is 20% and standard of care therapies have not changed in decades. This study evaluates the efficacy and stability of the JS-K-F49V nanoparticle formulation in monoculture of primary AML patient samples and a co-culture pseudo bone marrow model using HS-5 and HL-60 cell lines. Our efforts aim to assess the therapeutic potential of JS-K to induce apoptosis and support clinical development.
Presenter Name: Starr Joe
Presentation Type: Poster
Presentation Format: In Person
Presentation #50
College: Medicine
School / Department: Oncological Sciences
Research Mentor: Paul Shami
Additional Mentor: Greg Poffenberger
Time: 10:40 AM
Physical Location or Zoom link:
Ballroom